Hannover Re Shares Surge Following UBS Recommendation Upgrade

Shares of the German reinsurer Hannover Re experienced a significant rally on Friday, propelled by a major upgrade from investment bank UBS. The stock climbed more than 3% in Frankfurt trading after UBS raised its rating from “Neutral” to “Buy,” making it one of the top performers within the DAX index for the session.

A Rare Discount and Strategic Strengths

UBS analysts highlighted that the market is currently undervaluing Hannover Re’s unique non-technical capabilities. They pointed to the company’s exceptional resilience within a challenging and softening insurance cycle as a key strength. The upgrade was largely driven by the finding that the reinsurer is trading at a rare discount compared to both the broader sector and its direct peers, presenting a compelling entry opportunity for investors.

A central element in the bullish assessment is Hannover Re’s strategic approach to the retrocessions market. The company maintains robust reserve buffers and employs an effective retrocessions strategy, ceding a higher proportion of its gross premiums to retrocession partners—approximately 15%. This figure provides a distinct competitive advantage over its European rivals, who typically cede between 4% and 7%. This proactive risk management framework is seen as a critical factor in delivering more stable earnings, even as pricing comes under pressure.

This positive development follows a period of relative underperformance for the stock. Since the start of the year, Hannover Re’s share price had largely moved sideways while competitors saw average gains of around 10%.

Should investors sell immediately? Or is it worth buying Hannover Re?

Stable Outlook for 2026 Renewals

Looking ahead, Hannover Re anticipates that the environment for the upcoming January 1, 2026, contract renewals will remain attractive, despite moderating prices across the global reinsurance market. The company forecasts that overall pricing will be stable to slightly lower.

Furthermore, during the recent Monte Carlo Rendezvous conference, Hannover Re reaffirmed its commitment to Insurance-Linked Securities (ILS) and detailed plans for a new catastrophe sidecar, named Hannover Re Capital Partners (HCP).

Investor attention is now turning to the third-quarter statement for the period ending September 30, 2025, which is scheduled for release on November 9. The company has reiterated its full-year 2025 guidance, confirming an expected group net income of approximately €2.4 billion. This forecast is contingent on the absence of unforeseen capital market disruptions or major loss events that exceed budgeted levels.